The American Medical Association (AMA) has advocated for insurance companies and federal payers to fully cover new obesity treatments, such as Wegovy and Ozempic, despite their high costs. The AMA recognises obesity as a significant health concern and has passed a resolution supporting health insurance coverage for FDA-approved obesity treatments. Medicare currently doesn’t cover weight-loss drugs, and private insurers often view such treatments as non-essential, but change may be on the horizon.
Ransomware Gangs Seek Pen Testers to Boost Quality
Ransomware groups and cybercriminal organisations are hiring cybersecurity professionals to create ransomware and improve their existing attack tools, according to a report by Cato Networks.
